The NPaCA State of the Nation Patient and Public Report 2025 presents the results for people diagnosed with pancreatic cancer in England (2021-2022) and in Wales (2022-2023).
There is also a version of this report for healthcare professionals which can be found here.
The National Pancreatic Cancer Audit (NPaCA) aims to evaluate the patterns of care and outcomes for people diagnosed with pancreatic cancer in England and Wales, in line with its Quality Improvement Plan.
The NPaCA has a number of specific quality improvement goals, which are as follows:
- Increase the percentage of people who have diagnostic procedures and a process of diagnosis consistent with national recommendations for pancreatic cancer
- Optimise diagnostic and treatment pathways to reduce the time between referral and start of disease-targeted treatment
- Increase the percentage of people with pancreatic cancer (who are fit enough for treatment) who receive disease-targeted treatment (surgery, chemotherapy, radiotherapy – both curative and palliative)
- Increase the percentage of people with pancreatic cancer who receive supportive care (care that helps the person to live as well as possible with their cancer and its treatment) in line with national recommendations
- Improve outcomes for people diagnosed with pancreatic cancer.